NCT07739810

Brief Summary

This prospective observational study aims to evaluate the accuracy, safety, and feasibility of the Wireless MicroPremVitals Button Sensor System for continuous monitoring of electrocardiography (ECG), heart rate, respiratory rate, oxygen saturation, and skin temperature in newborn infants in the delivery room. Measurements obtained from the wireless sensor system will be compared with standard-of-care monitoring. The study will also assess skin tolerability, signal quality, and parent and healthcare provider perceptions of the device.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
12mo left

Started Sep 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 28, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

Wireless monitoringVital signsNewbornNeonateDelivery roomWearable sensorElectrocardiographyRespiratory rateSkin temperature

Outcome Measures

Primary Outcomes (3)

  • Electrocardiography (ECG) Accuracy

    Agreement between ECG measurements obtained using the Wireless MicroPremVitals Button Sensor System and the standard-of-care Dräger Infinity M540 monitor.

    During two 15-minute monitoring periods within the first 90 minutes after birth

  • Skin Temperature Accuracy

    Agreement between skin temperature measurements obtained using the Wireless MicroPremVitals Button Sensor System and the standard-of-care Dräger Infinity M540 monitor.

    During two 15-minute monitoring periods within the first 90 minutes after birth.

  • Oxygen Saturation (SpO₂) Accuracy

    Agreement between oxygen saturation (SpO₂) measurements obtained using the Wireless MicroPremVitals Button Sensor System and the standard-of-care Dräger Infinity M540 monitor.

    During two 15-minute monitoring periods within the first 90 minutes after birth.

Secondary Outcomes (2)

  • Heart Rate Accuracy

    During two 15-minute monitoring periods within the first 90 minutes after birth.

  • Heart Rate Variability (HRV)

    During two 15-minute monitoring periods within the first 90 minutes after birth.

Study Arms (1)

Newborn Infants

Healthy newborn infants enrolled in the study who will undergo simultaneous monitoring with the Wireless MicroPremVitals Button Sensor System and standard-of-care monitoring in the delivery room to evaluate the accuracy, safety, and feasibility of the wireless monitoring system.

Device: Wireless MicroPremVitals Button Sensor

Interventions

A wireless wearable sensor system applied to newborn infants in the delivery room to continuously measure electrocardiography (ECG), heart rate, respiratory rate, oxygen saturation, and skin temperature. Measurements will be compared with standard-of-care monitoring for validation purposes only and will not be used for clinical decision-making.

Newborn Infants

Eligibility Criteria

AgeUp to 24 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Healthy newborn infants in the delivery room at the study site who are eligible for routine delivery room monitoring and whose parent(s) or legal guardian provide informed consent for study participation.

You may qualify if:

  • \- Infants born by C-Section or vaginal delivery, with ≥35 weeks of gestational age and judged clinically stable immediately after birth.

You may not qualify if:

  • Infants with skin abnormality would potentially increase the risk of injury.
  • Family experiencing too much stress as determined by an attending physician or bedside care team, to not be approached for recruitment.
  • Infants born at \<35 weeks gestational age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Guilherme Sant'Anna, MD, PhD

    RI-MUHC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alyssa Maximov, BSc.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neonatologist

Study Record Dates

First Submitted

July 28, 2026

First Posted

July 31, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

July 31, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share